Home › Acute Myeloid Leukemia › Minnesota › Rochester
Pag-aaral pangklinika para sa Acute Myeloid Leukemia sa Rochester, MN
Isang pag-aaral para sa Acute Myeloid Leukemia ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Rochester. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
Nagre-recruitPhase 2
- Mayo Clinic in Rochester, Rochester
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
Nagre-recruitPhase 2
- Mayo Clinic in Rochester, Rochester
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
Nagre-recruitPhase 3
- Mayo Clinic in Rochester, Rochester
Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML
Nagre-recruitPhase 1/2
- Mayo Clinic, Rochester
Revumenib in Combination With Azacitidine + Venetoclax in Patients NPM1-mutated or KMT2A-rearranged AML
Nagre-recruitPhase 3
- US-Rochester MN-MAYOMN, Rochester
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
Nagre-recruitPhase 1/2
- Mayo Clinic in Rochester, Rochester
A Vaccine (VSV-hIFNβ-NIS) With or Without Cyclophosphamide and Combinations of Ipilimumab, Nivolumab, and Cemiplimab in Treating Relapsed or Refractory Multiple Myeloma, Acute Myeloid Leukemia or Lymphoma
Nagre-recruitPhase 1
- Mayo Clinic in Rochester, Rochester
A Study of CTX-712 in Relapsed/Refractory Acute Myeloid Leukemia and Higher Risk Myelodysplastic Syndromes
Nagre-recruitPhase 1/2
- Mayo Clinic Comprehensive Cancer Center, Rochester
Immune Profile of Acute Myeloid Leukemia Patients Receiving Azacitidine Plus Venetoclax Induction Chemotherapy
Nagre-recruitObservasyonal na pag-aaral
- Mayo Clinic in Rochester, Rochester
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
Nagre-recruitPhase 1
- Mayo Clinic - Rochester, Rochester
A Phase 1 Study of STX-0712 in Patients With Advanced Hematological Malignancies (CMML and AML)
Nagre-recruitPhase 1
- Mayo Clinic, Rochester
Specialty Compared to Oncology Delivered Palliative Care for Patients With Acute Myeloid Leukemia
Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
- Mayo Clinic, Rochester
Pag-aaral para sa Acute Myeloid Leukemia sa ibang lungsod
- Houston, TX85 pag-aaral
- New York City, NY51 pag-aaral
- Boston, MA44 pag-aaral
- Seattle, WA41 pag-aaral
- Baldwin Park, CA40 pag-aaral
- Columbus, OH35 pag-aaral
- Philadelphia, PA34 pag-aaral
- Durham, NC33 pag-aaral
- Atlanta, GA31 pag-aaral
- Tampa, FL29 pag-aaral
- Chicago, IL26 pag-aaral
- Portland, OR25 pag-aaral
Iba pang pag-aaral sa Rochester
- Kanser sa Suso42 pag-aaral
- Non-Small Cell Lung Cancer37 pag-aaral
- Metastatic Cancer31 pag-aaral
- Kanser (lahat ng uri)30 pag-aaral
- Kanser sa Ovary29 pag-aaral
- Colorectal Cancer29 pag-aaral
- Multiple Myeloma24 pag-aaral
- Pagkabigo ng Puso22 pag-aaral
- Kanser sa Prostate22 pag-aaral
- Kanser sa Pancreas22 pag-aaral
- Kanser ng Endometrium20 pag-aaral
- Kanser sa Baga20 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.